FIELD: medicine.
SUBSTANCE: group of inventions relates to medicine and method of producing binding agent or mixture of binding agents, capable to bind with epitope, contained in amino acid sequence, corresponding to C-end part of pre-vasopressin, consisting of amino acids 146-163, but not containing amino acid 164, where said method includes steps of producing binding agent with help of forming agent; determination binding ability of binding agent with amino acid sequence with length of at least 12 amino acids, contained in amino acid sequence, corresponding to C-end part, but not containing amino acid 164 of pre-vasopressin; selection of binding agent from multitude of binding agents. Group of inventions also relates to forming agent for producing binding agent or mixture of binding agents; application of binding agent for qualitative or quantitative detection of pre-vasopressin or its fragments in biological sample.
EFFECT: group of inventions provides qualitative or quantitative detection of pre-vasopressin or its fragments in biological sample.
20 cl, 1 ex, 5 dwg, 2 tbl
Title | Year | Author | Number |
---|---|---|---|
NEW BINDING MOLECULES WITH ANTI-TUMOUR ACTIVITY | 2013 |
|
RU2627185C1 |
MOLECULAR MIMETICS OF MENINGOCOCCUS B EPITOPE THAT INDUCE PRODUCTION OF FUNCTIONALLY ACTIVE ANTIBODY | 2002 |
|
RU2322451C2 |
BIOMARKERS FOR DIAGNOSIS, PREDICTION, ASSESSMENT AND STRATIFICATION OF FAINTING THERAPY | 2013 |
|
RU2613885C2 |
MONOCLONAL ANTIBODY DIRECTED AGAINST GNA33 PEPTIDE AND ITS APPLICATION | 2002 |
|
RU2355704C2 |
ANTI-CD79b ANTIBODIES AND IMMUNOCONJUGATES AND METHODS FOR USING THEM | 2009 |
|
RU2553566C2 |
PREDICTION OF CLINICAL OUTCOMES IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE | 2013 |
|
RU2688168C2 |
gp41-NEUTRALIZING ANTIBODIES AND THEIR APPLICATION | 2012 |
|
RU2624046C2 |
ANTI-CD79b ANTIBODIES AND IMMUNOCONJUGATES AND METHODS FOR USING THEM | 2008 |
|
RU2511410C2 |
COMPOSITIONS AND METHODS FOR DIAGNOSTICS AND TREATMENT OF DISEASES ASSOCIATED WITH NEURITES DEGENERATION | 2013 |
|
RU2644337C2 |
USING ANTI-TAU PS422 ANTIBODY FOR TREATING CEREBROPATHIES | 2010 |
|
RU2536247C2 |
Authors
Dates
2017-01-10—Published
2012-06-26—Filed